Add Yahoo as a preferred source to see more of our stories on Google. Valeant Pharmaceuticals Intl Inc (NYSE: VRX) stock spiked higher by more than 15 percent on Tuesday morning after the company ...

Troubled Valeant has been spinning its wheels over the past year trying to stage a turnaround that still seems light-years away. But now, it’s changing executive compensation, hoping to get some of ...

Valeant Pharmaceuticals International has forged its biggest deal since a “rebirth” of the Costa Mesa drug maker slightly more than a year ago. The company last week said it plans to buy Xcel ...

The colorful, storied history of Valeant Pharmaceuticals International in Orange County is turning a page—and likely coming to a close. Last week, the Aliso Viejo drug maker, which began life as Costa ...

Image source: Taxcredits.net via Flickr. What: AfterValeant Pharmaceuticals (NYSE: VRX)reassured investors on Tuesday that it can still deliver on its previously issued full-year financial guidance, ...

Valeant Pharmaceuticals has a new distribution deal with Walgreens, sending shares of the beleaguered Canadian drug company up sharply in morning trading. The company said Tuesday that the agreement ...

Bausch Health agreed to pay the SEC $45 million to settle Valeant Pharmaceuticals (former name) accounting fraud schemes. Three former executives, former CEO Michael Pearson, CFO Howard Schiller and ...

Valeant CEO Joseph Papa has put innovation at the forefront of a campaign to help the drug maker recover from debt and $700 million in losses from drug competition. The keys to success, Papa says, are ...

(Reuters) - Valeant Pharmaceuticals International Inc (VRX.TO)(VRX.N) said on Tuesday it will change its name to Bausch Health Companies Inc as it seeks to distance itself from a series of scandals ...

The board of Laval, Quebec, Canada-based Valeant Pharmaceuticals has launched a search for a new CEO to replace J. Michael Pearson, who has served as CEO since 2008. Here are seven things to know ...

NEW YORK (Reuters) - Valeant Pharmaceuticals International Inc sought to reassure doctors on Monday that the company's decision to cut ties to a controversial specialty pharmacy would not disrupt ...